Navigation Links
Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
Date:3/29/2011

SANTA ROSA, Calif., March 29, 2011 /PRNewswire/ -- Osseon® Therapeutics announced today at the Society of Interventional Radiology's (SIR) Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp.  The steerable bone tamp is designed to allow percutaneous access to sclerotic bone.  The Osseoflex BT features the same proprietary technology found in the Osseoflex® Steerable Needle and Osseoflex® DR Steerable Drill.  The Osseoflex BT articulates up to 60 degrees( and, when used in conjunction with the Osseoflex Needle, the Bone Tamp allows unipedicular access to vertebral compression fractures previously considered inaccessible due to dense, sclerotic bone or malignant tissue.  The Bone Tamp also provides clinicians with a percutaneous access option to cancellous bone in other areas of the body.

"The Osseoflex BT is the newest addition to the Osseon suite of steerable, minimally invasive devices," said John Stalcup, Ph.D., Osseon's CEO. "In the coming months, we will continue to develop and introduce complementary innovative products to address physician and patient needs."

Osseon Therapeutics currently markets the Osseoflex Steerable Needle, Osseoperm® Bone Cement, Osseoflex DR Steerable Drill, and Osseoflex Access Kit.  Together, the Osseoplasty Suite represents unparalleled products for physicians involved in the treatment vertebral compression fractures associated with osteoporosis, myelomas, and acute trauma.


'/>"/>
SOURCE Osseon Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
2. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
3. Reportlinker Adds Therapeutics for Immune System Disorders
4. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
5. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
6. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
7. Echo Therapeutics Announces 2010 Financial Results
8. Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
9. Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
10. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
11. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):